ProShares UltraShort NASDAQ Biotechnology Share Price

$12.03

+0.13 (1.09%)

BUY SELL

Live ProShares UltraShort NASDAQ Biotechnology Share Price Chart

O H L

ProShares UltraShort NASDAQ Biotechnology Performance Overview

Days Range

▼

$11.90Low

$11.93High

Markets Today

Previous Close	$12.10
Open	$11.90
Volume	5,610
Day's Range	$11.90 - $11.93
52W Range	$10.51 - $28.48

Historical Performance

1M Returns	NA
3M Returns	NA
6M Returns	NA
1Y Returns	NA
5Y Returns	NA
10Y Returns	NA

ProShares UltraShort NASDAQ Biotechnology Fundamentals

Avg. PE Ratio	0.00
Avg. PB Ratio	N/A

Avg. PE Ratio	0.00
Avg. PB Ratio	N/A

ProShares UltraShort NASDAQ Biotechnology Peer Comparison

Company	LTP(NAV)	Change	Change %	Asset(Cr.)	Exp Ratio
AAA	24.86	0.01	0.04%	NA	NA
AA AAAA	14.67	0.08	0.26%	NA	NA
AA AAAC	17.03	-0.04	-0.22%	NA	NA
AA AAAD	23.60	NA	NA	NA	NA
AAAP	12.72	-0.01	-0.02%	NA	NA
NOVZ	22.91	0.26	0.55%	NA	NA
RI RISE	17.42	0.18	0.96%	NA	NA
RT RTYY	6.75	0.15	1.82%	NA	NA
RULE	14.37	0.18	0.61%	NA	NA
TPZ	16.00	0.84	4.01%	NA	NA

About ProShares UltraShort NASDAQ Biotechnology

PROSHARES ULTRASHORT NAS BIO

Popular ETFs

Frequently Asked Questions

What is ProShares UltraShort NASDAQ Biotechnology (BIS) price today?

The ProShares UltraShort NASDAQ Biotechnology (BIS) price as of September 17, 2026 is $12.03. If you are investing from India, you can check the value in INR before investing.

Can I buy ProShares UltraShort NASDAQ Biotechnology (BIS) shares?

Yes, Indian investors can buy ProShares UltraShort NASDAQ Biotechnology (BIS) in the US market by opening an International Trading Account with Angel One.

How to buy ProShares UltraShort NASDAQ Biotechnology (BIS) Shares in India?

Indian investors can buy ProShares UltraShort NASDAQ Biotechnology (BIS) through the following modes:
1. Direct investment: One can invest through opening an International Trading Account with Angel One. Once account is opened, you can add funds in U.S. dollars to buy ProShares UltraShort NASDAQ Biotechnology (BIS).
2. Indirect investment: One can invest indirectly in ProShares UltraShort NASDAQ Biotechnology (BIS) through mutual funds and Exchange Traded Funds (ETFs) that offer exposure to global stocks.